Can HCV RNA Be Detected in Saliva of Egyptian Children Receiving Frequent Blood Transfusions?

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients

Awareness and satisfaction of the National Hepatitis C Virus screening campaign among a sample of the general population in Egypt.

Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients

Quantitative and Qualitative Evaluation of Hepatitis C Virus Core Antigen (HCVcAg) as an Alternative Diagnostic Marker in Chronic HCV Infection

EVALUATION OF THE IMPACT OF HLA-G 14BP POLYMORPHISM ON THE SUSCEPTIBILITY OF HEPATITIS C VIRUS INFECTION IN EGYPTIAN PATIENTS

Role of Anti-Hepatitis C Virus (HCV) Signal to Cut-off Ratio (S/CO) in Following- up Patients Received Anti-HCV Therapy in Egypt

Genetic variability of NS5B region of Hepatitis C Virus patients in Egypt

Evaluation of Sofosbuvir plus Ribavirinin Treatment of Cirrhotic Hepatitis C Patients: An Egyptian Study

Screening Program for Hepatitis C Virus and Its’ Risk Factors in Ismailia Governorate Egypt